ADAMTS13 reduces VWF-mediated acute inflammation following focal cerebral ischemia in mice

M M Khan1, D G Motto, S R Lentz

  • 1Department of Internal Medicine, University of Iowa, Iowa City, IA 52242, USA.

Abstract

Insights

ADAMTS13 deficiency exacerbates ischemic stroke injury by increasing VWF-mediated inflammation and neutrophil infiltration. Restoring ADAMTS13 function reduces brain damage, highlighting its protective role in stroke.

Area of Science:

  • Neuroscience
  • Hematology
  • Immunology

Background:

  • ADAMTS13 (a disintegrin and metalloproteinase with thrombospondin type 1 repeats 13) cleaves ultra-large von Willebrand factor (ULVWF) multimers.
  • The role of VWF-mediated inflammation in ADAMTS13 deficiency-associated brain injury is unclear.

Purpose of the Study:

  • To investigate if ADAMTS13 deficiency worsens ischemic brain injury via VWF-dependent vascular inflammation.
  • To test the hypothesis that VWF-mediated inflammation contributes to stroke severity in ADAMTS13-deficient mice.

Main Methods:

  • Transient focal cerebral ischemia induced by middle cerebral artery occlusion in mice.
  • Evaluation of myeloperoxidase (MPO) activity, inflammatory cytokines (IL-6, TNF-α), and neutrophil infiltration in the infarct zone.
  • Comparison between wild-type, ADAMTS13-deficient, VWF-deficient, and double-deficient mice, with and without neutrophil depletion.

Main Results:

  • ADAMTS13-deficient mice showed larger infarcts, increased MPO activity, neutrophil infiltration, and elevated IL-6 and TNF-α.
  • VWF deficiency reduced these inflammatory markers, indicating VWF's role in inflammation.
  • Mice lacking both ADAMTS13 and VWF had reduced inflammation, confirming VWF dependence.
  • Neutrophil depletion abrogated the increased infarct size in ADAMTS13-deficient mice.

Conclusions:

  • ADAMTS13 deficiency exacerbates ischemic stroke injury through VWF-dependent inflammation.
  • Neutrophils play a critical role in the enhanced brain injury observed in ADAMTS13 deficiency.
  • ADAMTS13 protects against VWF-mediated cerebral inflammation post-ischemic stroke.

Related Concept Videos